Other prognostic and predictive markers include estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2) for breast cancer, KRAS mutation for colon cancer, and anaplastic lymphoma kinase (ALK) mutation for lung cancer. Here, ERBB2 is linked to lung cancer.